10-Q Filing

Oruka Therapeutics, Inc. CIK: 907654 Q1 2016

Filing Information

Form Type	10-Q
Accession Number	`0001564590-16-019116`
Period End Date	20160331
Filing Date	20160511
Fiscal Year	2016
Fiscal Period	Q1
XBRL Instance	abio-20160331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 47 Income Statement 21 Cash Flow Statement 42 Stockholders Equity 19

Balance Sheet 47 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$12.18M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.72M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.06M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.05M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$38.80M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.06M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.05M	shares	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$910.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$114.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$391.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$31.02M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$38.92M	USD	Point-in-time
Marketable securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$5.31M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$28.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$24.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$580.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$630.00K	USD	Point-in-time
Total assets	`Assets`	$36.93M	USD	Point-in-time
Total assets	`Assets`	$39.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$364.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$744.00K	USD	Point-in-time
Payable for purchases of marketable securities	`PayablesToBrokerDealersAndClearingOrganizations`	$1.01M	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$669.00K	USD	Point-in-time
Accrued compensation and employee benefits	`EmployeeRelatedLiabilitiesCurrent`	$152.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$471.00K	USD	Point-in-time
Accrued expenses and other liabilities	`OtherAccruedLiabilitiesCurrent`	$439.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.34M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.50M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at March 31, 2016 and December 31, 2015; 9,056,647 and 9,051,217 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Common stock, $0.001 par value; 100 million shares authorized at March 31, 2016 and December 31, 2015; 9,056,647 and 9,051,217 shares issued and outstanding at March 31, 2016 and December 31, 2015, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$134.13M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$134.28M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$6.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-99.71M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-96.07M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$14.74M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$34.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$38.07M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$36.93M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$39.57M	USD	Point-in-time

Income Statement 21 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.59M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.71M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.04M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.07M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$3.67M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$2.74M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.67M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.74M	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$21.00K	USD	1 Quarter
Interest and other income	`InterestAndOtherIncome`	$1.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$1.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.45M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.74M	USD	1 Quarter
Change in unrealized gain on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$6.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.64M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-2.74M	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.40	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.91	USD	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.05M	shares	1 Quarter
Basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	3.02M	shares	1 Quarter

Cash Flow Statement 42 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-11.45M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.74M	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$5.00K	USD	1 Quarter
Depreciation	`DepreciationAndAmortization`	$4.00K	USD	1 Quarter
Amortization of other assets	`AdjustmentForAmortization`	$31.00K	USD	1 Quarter
Amortization of other assets	`AdjustmentForAmortization`	$57.00K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$155.00K	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$130.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$139.00K	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$277.00K	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherNoncurrentAssets`	$7.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$380.00K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-144.00K	USD	1 Quarter
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-206.00K	USD	1 Quarter
Accrued compensation and employee benefits	`IncreaseDecreaseInEmployeeRelatedLiabilities`	$-517.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-43.00K	USD	1 Quarter
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-32.00K	USD	1 Quarter
Other	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-2.00K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.11M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.88M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.00K	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.00K	USD	1 Quarter
Purchases of marketable securities	`PaymentsToAcquireAvailableForSaleSecurities`	$5.20M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-2.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-5.20M	USD	1 Quarter
Repayment of principal on vendor finance agreement	`RepaymentsOfShortTermDebtMaturingInMoreThanThreeMonths`	$55.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-55.00K	USD	1 Quarter
Net decrease in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-9.09M	USD	1 Quarter
Net decrease in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-3.17M	USD	1 Quarter
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$12.18M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$29.72M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$38.80M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$12.18M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$29.72M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$38.80M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$15.35M	USD	Point-in-time
Interest paid	`InterestPaid`	$1.00K	USD	1 Quarter
Vendor finance agreement	`VendorFinanceAgreement`	$138.00K	USD	1 Quarter
Change in unrealized gain on marketable securities	`AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax`	$6.00K	USD	1 Quarter
Payable for purchases of marketable securities	`MarketableSecuritiesPurchasedAndPayableToBroker`	$1.01M	USD	1 Quarter

Stockholders Equity 19 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, shares	`CommonStockSharesOutstanding`	9.06M	shares	Point-in-time
Beginning Balance, shares	`CommonStockSharesOutstanding`	9.05M	shares	Point-in-time
Beginning Balance	`StockholdersEquity`	$14.74M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$34.58M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$38.07M	USD	Point-in-time
Issuance of common stock for cash, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$34.17M	USD	Annual
Issuance of common stock upon vesting of Restricted Stock Units, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	Annual
Issuance of common stock upon vesting of Restricted Stock Units, value	`StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures`	-	USD	1 Quarter
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$599.00K	USD	Annual
Share-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$155.00K	USD	1 Quarter
Change in unrealized gain on marketable securities	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$6.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-11.45M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.74M	USD	1 Quarter
Ending Balance, shares	`CommonStockSharesOutstanding`	9.06M	shares	Point-in-time
Ending Balance, shares	`CommonStockSharesOutstanding`	9.05M	shares	Point-in-time
Ending Balance	`StockholdersEquity`	$14.74M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$34.58M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$38.07M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.